Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02LJQ
|
|||
| Drug Name |
Boronic acid derivative 1
|
|||
| Synonyms |
PMID26413912-Compound-58
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
INFINITY PHARMACEUTICALS, INC. AUSTAD, Brian, C. GRENIER, Louis GROGAN, Michael, J. LIU, Tao LO, Ching Kam MARTINOT, Theodore, A. YU, Lin-Chen
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C12H9BF2O2
|
|||
| Canonical SMILES |
B(C1=C(C=C(C=C1)C2=CC(=CC=C2)F)F)(O)O
|
|||
| InChI |
1S/C12H9BF2O2/c14-10-3-1-2-8(6-10)9-4-5-11(13(16)17)12(15)7-9/h1-7,16-17H
|
|||
| InChIKey |
WAWBMXWYDGQRBT-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Fatty acid amide hydrolase (FAAH) | Target's Patent Info | [1] | |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Fatty acid amide hydrolase inhibitors: a patent review (2009-2014).Expert Opin Ther Pat. 2015;25(11):1247-66. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.